Modernizing cell culture processes for the next wave of genomic medicine

With genomic medicine gaining clinical momentum, developers are looking for more robust ways to achieve viral vector scale-up. Pharmaceutical Technology spoke with Nicole Faust, PhD, General Manager, Cell Line Development, Cytiva, and Clive Glover, PhD, General Manager, Gene Therapy, Pall Corporation, to learn about recent developments.